Cargando…

Resection of colorectal liver metastases following neoadjuvant chemotherapy

BACKGROUND/AIMS: Hepatic resection in metastatic disease from colorectal cancer offers the best chance in selected cases for long-term survival. Neoadjuvant chemotherapy (NACT) has been advocated in some cases initially deemed irresectable, with few reports of the efficacy of such a strategy and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiappa, A, Bertani, E, Biffi, R, Pace, U, Viale, G, Pruneri, G, Zampino, G, Fazio, N, Orsi, F, Bonomo, G, Monfardini, L, Vigna, P Della, Andreoni, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223977/ https://www.ncbi.nlm.nih.gov/pubmed/22275956 http://dx.doi.org/10.3332/ecancer.2008.58

Ejemplares similares

Prognostic factors affecting survival after surgical resection of gastrointestinal stromal tumours: a two-unit experience over 10 years
por: Chiappa, Antonio, et al.
Publicado: (2006)

Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients
por: Andreoni, Bruno, et al.
Publicado: (2007)

Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of Oncology
por: Biffi, R, et al.
Publicado: (2008)

Hepatic intra-arterial chemotherapy in patients with advanced primary liver tumours
por: Spada, Francesca, et al.
Publicado: (2012)

Metachronous Colon Metastases from Gastric Adenocarcinoma: A Case Report
por: Pace, Ugo, et al.
Publicado: (2009)

Tips and tricks for a safe and effective image-guided percutaneous renal tumour ablation
por: Mauri, Giovanni, et al.
Publicado: (2017)

Surgical ‘damage control’ treatment of a large retroperitoneal liposarcoma encasing a horseshoe kidney
por: Andreoni, B, et al.
Publicado: (2008)

Effect of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases
por: Zhu, Dexiang, et al.
Publicado: (2014)

Optimizing Loco Regional Management of Oligometastatic Colorectal Cancer: Technical Aspects and Biomarkers, Two Sides of the Same Coin
por: Mauri, Giovanni, et al.
Publicado: (2021)

Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases
por: Ichida, Hirofumi, et al.
Publicado: (2019)

Is neoadjuvant chemotherapy necessary for patients with initially resectable colorectal liver metastases in the era of effective chemotherapy?
por: Son, Sang-Yong, et al.
Publicado: (2011)

ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care?
por: Flood, Michael P., et al.
Publicado: (2022)

Outcome of Microscopic Incomplete Resection (R1) of Colorectal Liver Metastases in the Era of Neoadjuvant Chemotherapy
por: Ayez, Ninos, et al.
Publicado: (2011)

The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis
por: Liu, Wei, et al.
Publicado: (2016)

Efficacy of neoadjuvant chemotherapy for initially resectable colorectal liver metastases: A retrospective cohort study
por: Takeda, Kazuhisa, et al.
Publicado: (2022)

Recurrence and prognostic factors in patients with aggressive fibromatosis. The role of radical surgery and its limitations
por: Bertani, Emilio, et al.
Publicado: (2012)

Neoadjuvant chemotherapy for patients with resectable colorectal cancer liver metastases: A systematic review and meta-analysis
por: Zhang, Yue, et al.
Publicado: (2021)

Neoadjuvant chemotherapy and radiotherapy followed by resection/ablation in stage IV rectal cancer patients with potentially resectable metastases
por: Li, Rongzhen, et al.
Publicado: (2021)

Hepatic resection after neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer: need for cautious planning
por: Kim, Young Il, et al.
Publicado: (2019)

Upgraded nomograms for the prediction of complications and survival in patients with colorectal liver metastases treated with neoadjuvant chemotherapy followed by hepatic resection
por: Chen, Qichen, et al.
Publicado: (2021)

Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases
por: Hawkes, Eliza A, et al.
Publicado: (2012)

Surgical site infections following colorectal cancer surgery: a randomized prospective trial comparing common and advanced antimicrobial dressing containing ionic silver
por: Biffi, Roberto, et al.
Publicado: (2012)

Safe liver resection following chemotherapy for colorectal metastases is a matter of timing
por: Welsh, F K S, et al.
Publicado: (2007)

Preoperative bi-fractionated accelerated radiation therapy for combined treatment of locally advanced rectal cancer in a consectutive series of unselected patients
por: Biffi, Roberto, et al.
Publicado: (2007)

Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial
por: Nasti, G, et al.
Publicado: (2013)

Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases
por: van den Broek, Maartje A. J., et al.
Publicado: (2009)

Neoadjuvant chemotherapy for colorectal liver metastases: A contemporary review of the literature
por: Guo, Marissa, et al.
Publicado: (2021)

Retroperitoneal pararenal isolated neurofibroma: report of a case and review of literature
por: Corbellini, C, et al.
Publicado: (2012)

Development of Personalized Therapeutic Strategies by Targeting Actionable Vulnerabilities in Metastatic and Chemotherapy-Resistant Breast Cancer PDXs
por: Punzi, Simona, et al.
Publicado: (2019)

Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial
por: Garufi, C, et al.
Publicado: (2010)

Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases
por: Gruenberger, Birgit, et al.
Publicado: (2008)

Predictive factors of histological response of colorectal liver metastases after neoadjuvant chemotherapy
por: Serayssol, Chloé, et al.
Publicado: (2019)

Biomarker evaluation in radically resectable locally advanced gastric cancer treated with neoadjuvant chemotherapy: an evidence reappraisal
por: Gervaso, Lorenzo, et al.
Publicado: (2021)

The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-Analysis
por: Flood, Michael P., et al.
Publicado: (2022)

A New Option for the Treatment of Intrahepatic Cholangiocarcinoma: Percutaneous Hepatic Perfusion with CHEMOSAT Delivery System
por: Ferrucci, Pier Francesco, et al.
Publicado: (2021)

Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
por: Versteijne, Eva, et al.
Publicado: (2022)

Technique of sentinel lymph node biopsy and lymphatic mapping during laparoscopic colon resection for cancer
por: Bianchi, PP, et al.
Publicado: (2007)

Local recurrence of renal cell carcinoma successfully treated with fusion imaging-guided percutaneous thermal ablation
por: Camisassi, Nicola, et al.
Publicado: (2020)

Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study
por: De Cobelli, Francesco, et al.
Publicado: (2022)

Neoadjuvant PD‐1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung
por: Feng, Yuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cvvgs8s6np5u68438enahrrnrh